Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
24.53
+0.54 (2.25%)
At close: Apr 28, 2026, 4:00 PM EDT
24.15
-0.38 (-1.55%)
After-hours: Apr 28, 2026, 6:13 PM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
19
Consensus Rating
Strong Buy
Price Target
$59.95
Upside
+144.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $67 | Buy | Maintains | $50 → $67 | +173.13% | Apr 16, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $61 → $25 | Strong Buy → Hold | Downgrades | $61 → $25 | +1.92% | Mar 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $120 → $74 | Buy | Maintains | $120 → $74 | +201.67% | Mar 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $79 | Strong Buy | Maintains | $128 → $79 | +222.05% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +38.61% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $39 → $37 | Buy | Maintains | $39 → $37 | +50.84% | Feb 17, 2026 |
| Wedbush | Wedbush | Hold Reiterates $25 | Hold | Reiterates | $25 | +1.92% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +103.83% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +144.60% | Feb 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +144.60% | Jan 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $64 → $52 | Strong Buy | Maintains | $64 → $52 | +111.99% | Jan 5, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $72 → $58 | Strong Buy | Maintains | $72 → $58 | +136.45% | Jan 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +185.36% | Dec 30, 2025 |
| Baird | Baird | Buy Maintains $72 → $47 | Buy | Maintains | $72 → $47 | +91.60% | Dec 30, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $65 → $45 | Buy | Maintains | $65 → $45 | +83.45% | Dec 30, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $114 → $63 | Strong Buy | Maintains | $114 → $63 | +156.83% | Dec 30, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.